Status:
UNKNOWN
Stem Cells and Resynchronization Cardiac
Lead Sponsor:
Instituto de Molestias Cardiovasculares
Collaborating Sponsors:
Medtronic
Conditions:
Heart Failure
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
Same patients with dilated myocardiopathies with large areas of fibrosis has not been as successful after Cardiac Resynchronization Therapy, for Heart Failure patients in functional class III or IV. T...
Detailed Description
About 120cc of blood are collected from the iliac bone marrow under epidural anesthesia.In the cell therapy lab this blood is harvested and mononuclear cells are separated.This procedure takes roughly...
Eligibility Criteria
Inclusion
- Dilated Cardiomyopathy
- Heart Failure
- Optimized Therapeutics
- Ventricular Desynchrony
- Functional Class III or IV
- Ejection Fraction(Echo/ Sympson) \< 35%
Exclusion
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00800657
Start Date
November 1 2008
End Date
December 1 2011
Last Update
June 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imc - Instituto de Moléstias Cardiovasculares
São José do Rio Preto, São Paulo, Brazil, 15015-210